Eppendorf tube 1.5mL (3/4 view, closed, full liquid)

[{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a39894e19c9/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a39894e19c9/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a7a364e19c8/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a7a364e19c8/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873ac22d4e19c7/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873ac22d4e19c7/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873ae04d4e19c6/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873ae04d4e19c6/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a49354e19c5/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a49354e19c5/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873abb514e19c4/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873abb514e19c4/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a25c24e19c3/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a25c24e19c3/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a070c4e19c2/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a070c4e19c2/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a4e184e19c1/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a4e184e19c1/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873acb464e19c0/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873acb464e19c0/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a7f1b4e19bf/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a7f1b4e19bf/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a02b54e19be/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a02b54e19be/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a01284e19bd/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a01284e19bd/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a72c04e19bc/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a72c04e19bc/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a2cdb4e19bb/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a2cdb4e19bb/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a664a4e19ba/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a664a4e19ba/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a220f4e19b9/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a220f4e19b9/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a163a4e19b8/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a163a4e19b8/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a03334e19b7/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a03334e19b7/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a14c24e19b6/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a14c24e19b6/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a9e794e19b5/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a9e794e19b5/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a900f4e19b4/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a900f4e19b4/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a446b4e19b3/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a446b4e19b3/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a833b4e19b2/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a833b4e19b2/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a0c7b4e19b1/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a0c7b4e19b1/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a50c34e19b0/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a50c34e19b0/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a08434e19af/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a08434e19af/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a3ac64e19ae/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a3ac64e19ae/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a07574e19ad/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a07574e19ad/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a544e4e19ac/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a544e4e19ac/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a76774e19ab/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a76774e19ab/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a17d04e19aa/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a17d04e19aa/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873af45f4e19a9/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873af45f4e19a9/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a1dd14e19a8/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a1dd14e19a8/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a032f4e19a7/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a032f4e19a7/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a55004e19a6/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a55004e19a6/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873abe274e19a5/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873abe274e19a5/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873a03164e19a4/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873a03164e19a4/65a69c503eab8229a69d19e6.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65a69c8add873ab1424e19a3/65a69c503eab8229a69d19e6.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65a69c8add873ab1424e19a3/65a69c503eab8229a69d19e6.png"}]